Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases

Diagnostic Microbiology and Infectious Disease

Volumn 59, Issue 4, 2007, Pages 433-437

  Romero, Emilio David Valverde ^a   Padilla, Trinidad Parras ^a   Hernández, Ana Herrero ^a   Grande, Rosa Pérez ^a   Vázquez, Marta Fernández ^a   García, Inmaculada García ^a   García Rodríguez, José Angel ^a,b   Muñoz Bellido, Juan Luis ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

ESBLs; Multiple ESBL; Prevalence; Spain

Indexed keywords

BACTERIAL ENZYME; CEPHALOSPORIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLONING; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC VARIABILITY; HOSPITAL PATIENT; KLEBSIELLA; KLEBSIELLA OXYTOCA; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEQUENCE ANALYSIS; SPAIN; TIME SERIES ANALYSIS;

BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SPAIN;

EID: 36549085957     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.06.007     Document Type: Article

References (34)

1. Arpin C., Dubois V., Coulange L., Andre C., Fischer I., Noury P., Grobost F., Brochet J.P., Jullin J., Dutilh B., Larribet G., Lagrange I., and Quentin C. Extended-spectrum β-lactamase producing Enterobacteriaceae in community and private health care centers. Antimicrob. Agents Chemother. 47 (2003) 3506-3514
2. Babini G.S., and Livermore D.M. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J. Antimicrob. Chemother. 45 (2000) 183-189
3. Batchelor M., Hopkins K., Threlfall E.J., Clifton-Hadley F.A., Stallwood A.D., Davies R.H., and Liebana E. blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob. Agents Chemother. 49 (2005) 1319-1322
4. Bauerfeind A., Casellas M., Goldberg M., Holley M., Jungwirth R., Mangold P., Rohnisch T., Schweighart S., and Wilhelm R. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20 (1992) 158-163
5. Bonnet R., Recule C., Baraduc R., Chanal C., Sirot D., De Champs C., and Sirot J. Effect of D240G substitution in a novel ESBL CTX-M 27. J. Antimicrob. Chemother. 52 (2003) 29-35
6. Bouallègue-Godet O., Ben Salem Y., Fabre L., Demartin M., Grimont P.A., Mzoughi R., and Weill F.X. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 43 (2005) 1037-1044
7. Brent R., Kingston R.E., and Seidman J.G. Current Protocols in Molecular Biology (2003), John Wiley and Sons, New York
8. Chanawong A., M ́Zali F.H., Heritage J., Xiong J.H., and Hawkey P.M. Three cefotaximases, CTX-M 9, CTX-M 13 and CTX-M 14, among Enterobacteriaceae in the People's Republic of China. Antimicrob. Agents Chemother. 46 (2002) 630-637
9. Chia J.H., Chu C., Su L., Chiu C.H., Kuo A.J., Sun C.F., and Wu T.L. Development of a multiplex PCR and SHV-melting curve mutation detection system for detection of some SHV and CTX-M β-lactamases of Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae in Taiwan. J. Clin. Microbiol. 43 (2005) 4486-4491
10. Coque T.M., Oliver A., Pérez-Díaz J.C., Baquero F., and Cantón R. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob. Agents Chemother. 46 (2002) 500-510
11. Gautom R.K. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other Gram-negative organisms in 1 day. J. Clin. Microbiol. 35 (1997) 2977-2980
12. Guan X.Z., Liu Y.N., Luo Y.P., She D.Y., Zhou G., Chen L.A., and Xu Y.P. DHA-1 type cephalosporinase accompanied with SHV-12 prevailed in clinical isolates of Klebsiella pneumoniae. Zhonghua Jie He He Hu Xi Za Zhi 28 (2005) 475-478
13. Hernández J.R., Martínez-Martínez L., Cantón R., Coque T.M., and Pascual A. Nationwide Study of Escherichia coli and K. pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49 (2005) 2122-2125
14. Jacoby G., and Bush K. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant β-lactamases (2006). http://www.lahey.org/studies/ (last accessed 07-30-2006)
15. Jeong S.H., Bae I.K., Lee J.H., Sohn S.G., Kang G.H., Jeon G.J., Kim Y.H., Jeong B.C., and Lee S.H. Molecular characterization of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J. Clin. Microbiol. 42 (2004) 2902-2906
16. Kliebe C., Nies B.A., Meyer J.F., Tolxdorff-Neutzling R.M., and Wiedemann B. Evolution of plasmid-coded resistance to broad spectrum cephalosporins. Antimicrob. Agents Chemother. 28 (1985) 302-307
17. Knothe H., Shah P., Kremery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11 (1983) 615-617
18. Mirelis B., Navarro F., Miró E., Mesa R.J., Coll P., and Prats G. Community transmission of extended-spectrum β-lactamase. Emerg. Infect. Dis. 9 (2003) 1024-1025
19. Miró E., Mirelis B., Navarro F., Rivera A., Mesa R.J., Roig M.C., Gomez L., and Coll P. Surveillance of extended-spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J. Antimicrob. Chemother. 56 (2005) 1152-1155
20. Mulvey M.R., Bryce E., Boyd D., Ofner-Agostini M., Christianson S., Simor A.E., and Paton S. Ambler class A extended-spectrum β-lactamase-producing E. coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48 (2004) 1204-1214
21. Munday C.J., Whitehead G.M., Tood N.J., Campbell M., and Hawkey P.M. Predominance and genetic diversity of community and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J. Antimicrob. Chemother. 54 (2004) 628-633
22. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement (M100-S15) (2005), NCCLS, Villanova, PA
23. Pai H., Hong J.Y., Byeon J.H., Kim Y.K., and Lee H.J. High prevalence of extended-spectrum β-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob. Agents Chemother. 48 (2004) 3159-3161
24. Rodríguez-Baño J., Navarro M.D., Romero L., Martinez-Martinez L., Muniain M.A., Perea E.J., Perez-Cano R., and Pascual A. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42 (2004) 1089-1094
25. Romero L., López L., Martínez-Martínez L., Guerra B., Hernandez J.R., and Pascual A. Characterization of the first CTX-M 14-producing Salmonella enterica serotype Enteritidis isolate. J. Antimicrob. Chemother. 53 (2004) 1113-1114
26. Ryoo N.H., Kim E.C., Hong S.G., Park Y.J., Lee K., Bae I.K., Song E.H., and Jeong S.H. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56 (2005) 698-702
27. Sabaté M., Tarragó R., Navarro F., Miro E., Verges C., Barbe J., and Prats G. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M 9) from Escherichia coli in Spain. Antimicrob. Agents Chemother. 44 (2000) 1970-1973
28. Sabaté M., Miró E., Navarro F., Verges C., Aliaga R., Mirelis B., and Prats G. β-Lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J. Antimicrob. Chemother. 49 (2002) 989-997
29. Saladin M., Cao V.T., Lambert T., Donay J.L., Herrmann J.L., Ould-Hocine Z., Verdet C., Delisle F., Philippon A., and Arlet G. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett. 209 (2002) 161-168
30. Sanguinetti M., Posteraro B., Spanu T., Ciccaglione D., Romano L., Fiori B., Nicoletti G., Zanetti S., and Fadda G. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum β-lactamase Detection Method. J. Clin. Microbiol. 41 (2003) 1463-1468
31. Shah P.M., and Stille W. Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. J. Antimicrob. Chemother. 11 (1983) 597-598
32. Simarro E., Navarro E., Ruiz J., Miro E., Gomez J., and Mirelis B. Salmonella enterica serovar Virchow with CTX-M-like beta-lactamase in Spain. J. Clin. Microbiol. 38 (2000) 4676-4678
33. Winokur P.L., Cantón R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin. Infect. Dis. 32 Suppl 2 (2001) S94-S103
34. Xiong Z., Zhu D., Wang F., Zhang Y., Okamoto R., and Inoue M. Investigation of extended-spectrum β-lactamase in K. pneumoniae and E. coli from China. Diagn. Microbiol. Infect. Dis. 44 (2002) 195-200